| Vial description: |
ANX5, Anchorin CII, Annexin V, CBP-IAP-I, Calphobindin I, ENX2P4, Endonexin II, Lipocortin V, VAC-alpha, Annexin-5 |
| Category: |
antigen |
| Raised in: |
laboratory |
| Clone: |
1 vial |
| Form: |
Purified |
| Reactivity: |
not determined |
| Purity: |
>, 95% |
| Molecular weight: |
1 kDa, 38 |
| Source: |
coli, E |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
P48036 |
| Application: |
not determined |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Conjugation: |
histidine |
| Gene target: |
His-tag), Annexin A5 / ANXA5 (1-319 |
| Short name: |
His-tag) Antibody, anti-Annexin A5 / ANXA5 (1-319 |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Label: |
His |
| Alternative name: |
histidine-detection labelled) (Antibody to), antibody to-Annexin A5 / annexin A5 (1-319 |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
ANX5 and ENX2 and HEL-S-7 and PP4 and RPRGL3, ANXA5 and IDBG-36172 and ENSG00000164111 and 308, Anxa5 and IDBG-138625 and ENSMUSG00000027712 and 11747, BT, Cell surfaces, calcium-dependent phospholipid binding, this GO :0004859 and phospholipase inhibitor activity and molecular function this GO :0005509 and calcium ion binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005543 and phospholipid binding and molecular function this GO :0005544 and calcium-dependent phospholipid binding and molecular function this GO :0005622 and intracellular and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0007165 and signal transduction and biological process this GO :0007596 and blood coagulation and biological process this GO :0009897 and external side of plasma membrane and cellular component this GO :0010033 and response to organic substance and biological process this GO :0016020 and membrane and cellular component this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043086 and negative regulation of catalytic activity and biological process this GO :0050819 and negative regulation of coagulation and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0072563 and endothelial microparticle and cellular component, this GO :0004859 : phospholipase inhibitor activity, this GO :0004859 : phospholipase inhibitor activity and also this GO :0005509 : calcium ion binding and also this GO :0005515 : protein binding and also this GO :0005543 : phospholipid binding and also this GO :0005544 : calcium-dependent phospholipid binding, this GO :0005509 : calcium ion binding, this GO :0005515 : protein binding, this GO :0005543 : phospholipid binding, this GO :0005544 : calcium-dependent phospholipid binding, 49277 and IDBG-639757 and ENSBTAG00000021746 and 281626, annexin A5 |
| Identity: |
543 |
| Gene: |
ANXA5 |
More about : ANXA5 |
| Long gene name: |
annexin A5 |
| Synonyms gene: |
ENX2 ANX5 |
| Locus: |
4q27 |
| Discovery year: |
1989-05-31 |
| GenBank acession: |
U05770 |
| Entrez gene record: |
308 |
| Pubmed identfication: |
2960376 |
| RefSeq identity: |
NM_001154 |
| Classification: |
Annexins |
| Havana BLAST/BLAT: |
OTTHUMG00000133034 |